Beijing Hotgen Biotech Co., Ltd. (SHA:688068)
China · Delayed Price · Currency is CNY 77.53
+1.43 (1.88%)
Jun 18, 2026, 3:00 PM CST
Beijing Hotgen Biotech Market Cap
Beijing Hotgen Biotech has a market cap or net worth of 6.82 billion as of June 18, 2026. Its market cap has decreased by -39.40% in one year.
Market Cap
6.82B
Enterprise Value
5.77B
Revenue
427.66M
Ranking
n/a
PE Ratio
n/a
Stock Price
77.53
Market Cap Chart
Since September 30, 2019, Beijing Hotgen Biotech's market cap has increased from 4.41B to 6.82B, an increase of 54.62%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 6.82B | -52.63% |
| Dec 31, 2025 | 14.39B | 159.78% |
| Dec 31, 2024 | 5.54B | 50.94% |
| Dec 29, 2023 | 3.67B | -34.53% |
| Dec 30, 2022 | 5.61B | -22.40% |
| Dec 31, 2021 | 7.22B | 197.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aurisco Pharmaceutical | 7.89B |
| Chengdu Easton Biopharmaceuticals | 7.85B |
| GemPharmatech | 7.82B |
| Daan Gene | 7.79B |
| Shanghai Medicilon | 7.50B |
| Sino Biological,Inc. | 7.37B |
| Bio-Thera Solutions | 7.06B |
| Acrobiosystems | 6.75B |